Viral infections in relation to age, atopy, and season of admission among children hospitalized for wheezing
- PMID: 15316497
- PMCID: PMC7185400
- DOI: 10.1016/j.jaci.2004.04.006
Viral infections in relation to age, atopy, and season of admission among children hospitalized for wheezing
Abstract
Background: Viral respiratory tract infections and atopy are associated with attacks of wheezing during childhood. However, information about the relationship between viral infections and atopy among children whose attacks of wheezing lead to hospitalization is unclear.
Objective: To evaluate the prevalence of viral respiratory tract pathogens among infants and children hospitalized for wheezing and to analyze the results in relation to the patient's age, atopic characteristics, and season of admission.
Methods: This was a case-control study of children (age 2 months to 18 years) admitted for wheezing to the University of Virginia Medical Center over a period of 12 months. Children without wheezing were enrolled as controls. Nasal secretions were evaluated for viral pathogens by using cultures, PCR tests, and antigen detection. Total IgE and specific IgE antibody to common aeroallergens was measured in serum.
Results: Seventy percent of children hospitalized for wheezing before age 3 years (n=79) were admitted between December and March, whereas 46% of children age 3 to 18 years (n=54) were hospitalized between September and November. Among children younger than 3 years, viral pathogens were detected in 84% (66/79) of wheezing children and 55% (42/77) of controls (P <.001). Respiratory syncytial virus was the dominant pathogen during the winter months, but rhinovirus was more common during other months. Total serum IgE levels were generally low, and values from wheezing and control subjects overlapped considerably. Among children 3 years and older, 61% (33/54) of subjects admitted for wheezing tested positive for virus (predominantly rhinovirus), compared with 21% (12/56) of controls (P <.001). The total serum IgE values among wheezing children (geometric mean, 386 IU/mL; 95% CI, 259-573) were substantially elevated compared with those of controls (geometric mean, 38 IU/mL; 95% CI, 26-56; P <.001). A significantly higher percentage of wheezing children compared with controls was sensitized to at least 1 of the inhaled allergens tested: 84% (36/43) compared with 33% (15/45; P <.001). The atopic characteristics of wheezing children who tested positive or negative for virus were similar.
Conclusions: Viral infections were the dominant risk factor for wheezing among children hospitalized before 3 years of age. By comparison, a large majority of the wheezing children age 3 to 18 years had striking atopic characteristics that may be critical as a risk factor for hospitalization and an adverse response to viral infections, especially infections caused by rhinovirus.
Figures





Comment in
-
The spectrum of severe wheezing in childhood.J Allergy Clin Immunol. 2004 Aug;114(2):236-8. doi: 10.1016/j.jaci.2004.05.059. J Allergy Clin Immunol. 2004. PMID: 15316496 Free PMC article. No abstract available.
-
Origins of atopy in pediatric asthma.J Allergy Clin Immunol. 2005 Feb;115(2):425-6; author reply 426. doi: 10.1016/j.jaci.2004.10.037. J Allergy Clin Immunol. 2005. PMID: 15696110 No abstract available.
-
Human metapneumovirus infection in children hospitalized for wheezing.J Allergy Clin Immunol. 2005 Jun;115(6):1311-2. doi: 10.1016/j.jaci.2005.02.001. J Allergy Clin Immunol. 2005. PMID: 15940152 Free PMC article. No abstract available.
Similar articles
-
Rhinovirus and respiratory syncytial virus in wheezing children requiring emergency care. IgE and eosinophil analyses.Am J Respir Crit Care Med. 1999 Mar;159(3):785-90. doi: 10.1164/ajrccm.159.3.9801052. Am J Respir Crit Care Med. 1999. PMID: 10051251
-
Risk factors for acute wheezing in infants and children: viruses, passive smoke, and IgE antibodies to inhalant allergens.Pediatrics. 1993 Oct;92(4):535-40. Pediatrics. 1993. PMID: 8414823
-
Predictive factor for first wheezing episode.Turk J Pediatr. 2015 Jul-Aug;57(4):367-73. Turk J Pediatr. 2015. PMID: 27186699
-
[Viral infection and asthma: immunologic mechanisms].Allergol Immunopathol (Madr). 2001 May-Jun;29(3):126-33. doi: 10.1016/s0301-0546(01)79032-5. Allergol Immunopathol (Madr). 2001. PMID: 11434887 Review. Spanish.
-
Viral Infections and Wheezing in Preschool Children.Immunol Allergy Clin North Am. 2022 Nov;42(4):727-741. doi: 10.1016/j.iac.2022.05.004. Epub 2022 Sep 24. Immunol Allergy Clin North Am. 2022. PMID: 36265972 Review.
Cited by
-
Virus-induced modulation of lower airway diseases: pathogenesis and pharmacologic approaches to treatment.Pharmacol Ther. 2015 Apr;148:185-98. doi: 10.1016/j.pharmthera.2014.12.005. Epub 2014 Dec 27. Pharmacol Ther. 2015. PMID: 25550230 Free PMC article. Review.
-
Role of leukotriene receptor antagonists in the management of pediatric asthma: an update.Paediatr Drugs. 2012 Oct 1;14(5):317-30. doi: 10.2165/11599930-000000000-00000. Paediatr Drugs. 2012. PMID: 22897162 Review.
-
Viral-associated exacerbations of asthma and COPD.Curr Opin Pharmacol. 2007 Jun;7(3):252-8. doi: 10.1016/j.coph.2006.11.010. Epub 2007 Mar 21. Curr Opin Pharmacol. 2007. PMID: 17369093 Free PMC article. Review.
-
The H antigen at epithelial surfaces is associated with susceptibility to asthma exacerbation.Am J Respir Crit Care Med. 2011 Jan 15;183(2):189-94. doi: 10.1164/rccm.201003-0488OC. Epub 2010 Aug 23. Am J Respir Crit Care Med. 2011. PMID: 20732988 Free PMC article.
-
Study of modifiable risk factors for asthma exacerbations: virus infection and allergen exposure increase the risk of asthma hospital admissions in children.Thorax. 2006 May;61(5):376-82. doi: 10.1136/thx.2005.042523. Epub 2005 Dec 29. Thorax. 2006. PMID: 16384881 Free PMC article.
References
-
- Centers for Disease Control and Prevention Measuring childhood asthma prevalence before and after the 1997 redesign of the National Health Interview Survey—United States. MMWR Morb Mortal Wkly Rep. 2000;49:908–911. - PubMed
-
- Loyano P., Sullivan S.D., Smith D.H., Weiss K.B. The economic burden of asthma in US children: estimates from the National Medical Expenditure Survey. J Allergy Clin Immunol. 1999;104:957–963. - PubMed
-
- Gergen P.J. Understanding the economic burden of asthma. J Allergy Clin Immunol. 2001;107:445–485. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical